Back | Next |
home / stock / hils / hils message board
Subject | By | Source | When |
---|---|---|---|
Price trading up | Triple nickle | investorshub | 04/21/2023 6:32:31 AM |
$HILS Found an interesting article | harry crumb | investorshub | 04/21/2023 5:41:00 AM |
bears are running | subslover | investorshub | 04/21/2023 1:33:31 AM |
$HILS Lets go go go go... Up up and away we go. | tw0122 | investorshub | 04/20/2023 11:17:45 PM |
$HILS Price gaining last trade up | Triple nickle | investorshub | 04/20/2023 8:48:59 PM |
Have a look at this | subslover | investorshub | 04/20/2023 5:01:47 PM |
Time for a bounce? | Runners123 | investorshub | 04/20/2023 1:30:19 PM |
$HILS The trading | stocks2watch | investorshub | 04/20/2023 9:52:30 AM |
$HILS The gaining | PennyPusher786 | investorshub | 04/20/2023 12:31:16 AM |
Found an interesting article | gail | investorshub | 04/20/2023 12:30:06 AM |
Have a look at this | velcro | investorshub | 04/19/2023 4:41:09 PM |
$HILS Price trading | Triple nickle | investorshub | 04/19/2023 11:06:46 AM |
Price trading last trade up | harry crumb | investorshub | 04/19/2023 9:09:01 AM |
great article | harry crumb | investorshub | 04/19/2023 8:24:22 AM |
Thoughts on where this is headed? | PennyPusher786 | investorshub | 04/19/2023 3:45:42 AM |
$HILS Price now | gail | investorshub | 04/19/2023 1:20:52 AM |
is it bear time? Or do we go bull? | harry crumb | investorshub | 04/18/2023 9:57:10 PM |
great article | velcro | investorshub | 04/18/2023 5:13:47 PM |
$HILS is it bear time? Or do we go bull? | harry crumb | investorshub | 04/18/2023 3:27:05 PM |
short squeeze all day | gail | investorshub | 04/18/2023 11:15:45 AM |
News, Short Squeeze, Breakout and More Instantly...
Hillstream BioPharma Inc. Company Name:
HILS Stock Symbol:
NASDAQ Market:
Expects to launch and complete a Phase 1 trial in Q4 2023 Tharimmune to begin trading under new ticker, THAR, on Monday September 25, 2023 BRIDGEWATER, NJ / ACCESSWIRE / September 22, 2023 / Hillstream BioPharma Inc., (NASDAQ:HILS), a biotechnology company developing innovative therapeu...
JUPITER, Fla., Sept. 21, 2023 (GLOBE NEWSWIRE) -- via InvestorWire -- Dawson James Securities, Inc. (“Dawson”), a full-service investment bank focused on emerging growth companies, today announces its 8 th Annual Dawson James Small Cap Growth Conferen...
Anticipate completion of Phase 1 & Phase 2 clinical trials in chronic pruritis over the next approximately 12 months Seeking first approval in an orphan disease, PBC, for the treatment of moderate to severe chronic pruritis in which more than 70% of patients suffer from chronic prur...